EdgarLookup

Inhibikase Therapeutics, Inc. — 4 Filings

76 4 filings on record

This page lists all 4 filings submitted to the SEC by Inhibikase Therapeutics, Inc. (IKT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Inhibikase Therapeutics, Inc. has filed 76 4 documents with the SEC since 2018. To view all SEC filings by Inhibikase Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 3/A 4 4/A 424B3 424B4 424B5 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS DRS/A DRSLTR EFFECT POS AM PRE 14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-8 SC 13D SC 13G SC 13G/A SC 14F1 SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
4 4 0001193125-26-068079 Feb 24, 2026 Feb 21, 2026
4 4 0001193125-26-068077 Feb 24, 2026 Feb 21, 2026
4 4 0001193125-26-068063 Feb 24, 2026 Feb 21, 2026
4 4 0001193125-26-006351 Jan 7, 2026 Jan 5, 2026
4 4 0001193125-26-006350 Jan 7, 2026 Jan 5, 2026
4 4 0001193125-26-006343 Jan 7, 2026 Jan 5, 2026
4 PRIMARY DOCUMENT 0001875620-25-000025 Nov 24, 2025 Nov 21, 2025
4 4 0001193125-25-191463 Aug 28, 2025 Feb 21, 2025
4 4 0000950170-25-093436 Jul 2, 2025 Jun 30, 2025
4 4 0000950170-25-093434 Jul 2, 2025 Jun 30, 2025
4 4 0000950170-25-093432 Jul 2, 2025 Jun 30, 2025
4 4 0000950170-25-093430 Jul 2, 2025 Jun 30, 2025
4 4 0000950170-25-093428 Jul 2, 2025 Jun 30, 2025
4 4 0000950170-25-093424 Jul 2, 2025 Jun 30, 2025
4 4 0000950170-25-054712 Apr 16, 2025 Apr 14, 2025
4 4 0000950170-25-026652 Feb 25, 2025 Feb 21, 2025
4 4 0000950170-25-026650 Feb 25, 2025 Feb 21, 2025
4 4 0000950170-25-026627 Feb 25, 2025 Feb 21, 2025
4 4 0000950170-25-023600 Feb 19, 2025 Feb 14, 2025
4 4 0000950170-25-023595 Feb 19, 2025 Feb 14, 2025
4 4 0000950170-25-023594 Feb 19, 2025 Feb 14, 2025
4 4 0000950170-25-023592 Feb 19, 2025 Feb 14, 2025
4 4 0000950170-25-023586 Feb 19, 2025 Feb 14, 2025
4 4 0000950170-25-023583 Feb 19, 2025 Feb 14, 2025
4 4 0000950170-25-023565 Feb 19, 2025 Feb 14, 2025
4 4 0000950170-25-007746 Jan 22, 2025 Jan 21, 2025
4 4 0000950170-25-007742 Jan 22, 2025 Jan 21, 2025
4 4 0000950170-25-007744 Jan 22, 2025 Jan 21, 2025
4 4 0000950170-25-007741 Jan 22, 2025 Jan 21, 2025
4 4 0000950170-25-003132 Jan 7, 2025 Jan 3, 2025
4 4 0000950170-25-003130 Jan 7, 2025 Jan 3, 2025
4 4 0000950170-25-003125 Jan 7, 2025 Jan 3, 2025
4 4 0000950170-25-003123 Jan 7, 2025 Jan 3, 2025
4 4 0000950170-24-116787 Oct 23, 2024 Oct 21, 2024
4 4 0000950170-24-116785 Oct 23, 2024 Oct 21, 2024
4 4 0000950170-24-116783 Oct 23, 2024 Oct 21, 2024
4 4 0000950170-24-116780 Oct 23, 2024 Oct 21, 2024
4 4 0000950170-24-084674 Jul 18, 2024 Jul 16, 2024
4 4 0000950170-24-084666 Jul 18, 2024 Jul 16, 2024
4 4 0000950170-24-084656 Jul 18, 2024 Jul 16, 2024
4 4 0000950170-24-084655 Jul 18, 2024 Jul 16, 2024
4 4 0000950170-24-041191 Apr 3, 2024 Apr 1, 2024
4 4 0000950170-24-040358 Apr 2, 2024 Apr 1, 2024
4 4 0000950170-23-031856 Jul 5, 2023 Jun 30, 2023
4 4 0000950170-23-031855 Jul 5, 2023 Jun 30, 2023
4 4 0000950170-23-031852 Jul 5, 2023 Jun 30, 2023
4 4 0000950170-23-031850 Jul 5, 2023 Jun 30, 2023
4 FORM 4 SUBMISSION 0000899243-23-007010 Mar 3, 2023 Mar 1, 2023
4 FORM 4 SUBMISSION 0000899243-23-007009 Mar 3, 2023 Mar 1, 2023
4 FORM 4 SUBMISSION 0000899243-22-030439 Sep 6, 2022 Sep 1, 2022